GlobalRPh Renal Dosing Masterv6.6
Evidence addition

Succimer - CHEMET oral capsules

Local official-label summaryBase record retrieved 2026-09-10See the evidence for this drug2 sources available - open source summaries, references and comparisons

CHEMET / succimer

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)
Review first - source-specific qualification

Removal of drug is not equivalent to removal of lead chelates

The selected official and mirror sections distinguish drug dialyzability from chelate removal.

Before applying: Keep toxicology assessment and monitoring attached. Do not derive a dialysis supplement from removal information alone.

Evidence for this qualification

Selected-source qualification; independent clinician review pending.

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (2)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

Official source

CHEMET - succimer capsules

Product / population
CHEMET oral succimer for its pediatric lead-poisoning indication; not prophylaxis or treatment of lead encephalopathy.
Renal measure
Qualitative renal impairment; no numeric clearance threshold supplied

Selected sections only; not a complete prescribing monograph or independent clinician approval.

Exact DailyMed HTML identity and named sections read. Raw SPL XML, original document hash and complete revision history were not obtained. Availability is not established by label retrieval.

Renal dosing, restrictions and evidence limits

The full prescribing-information renal subsection (8.5) supports baseline and periodic renal assessment during prolonged therapy, adequate hydration, and closer monitoring with a renal-impairment history. It distinguishes limited evidence of succimer dialyzability from non-dialyzability of lead chelates.

No clearance-band reduction or dialysis supplement is established by this paragraph. CBC/neutrophil and hepatic monitoring remain separate treatment safeguards. Follow the full renal subsection heading rather than relying solely on a highlights cross-reference.

Source revision: 9/2024 | Retrieved: 2026-09-10. Retrieval date is not the revision date.

Source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62035612-9505-3a3f-1ac8-e2dbd711d24e

Scope: Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-specific interpretation

What the dialysis evidence actually supports

Removal information alone does not define a maintenance dose, supplemental dose or dialysis schedule. A reported regimen still requires its product, indication, renal measure and dialysis assumptions to match the patient.

CHEMET - succimer capsules

Authored v5.8; retrieved 2026-09-10 - retained source, not freshly reviewed in this release

Removal information only - not a dialysis regimen

Read the source and its limits

GlobalRPh RX List - CHEMET

Authored v5.8; retrieved 2026-09-10 - retained source, not freshly reviewed in this release

Removal information only - not a dialysis regimen

Read the source and its limits

These manual classifications apply only to the identified selected sections, not every retained source or the entire prescribing information. They are not dosing clearance.

Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

Official product label

CHEMET - succimer capsules

Monitoring or renal-toxicity guidance. This finding concerns risk or surveillance; it may not establish a dose adjustment.

Dialysis evidence: Removal information only - not a dialysis regimen

CHEMET oral succimer for its pediatric lead-poisoning indication; not prophylaxis or treatment of lead encephalopathy.

Renal method: Qualitative renal impairment; no numeric clearance threshold supplied
Retrieved: 2026-09-10

Read local renal resultOpen original reference
GlobalRPh RX List

GlobalRPh RX List - CHEMET

Monitoring or renal-toxicity guidance. This finding concerns risk or surveillance; it may not establish a dose adjustment.

Dialysis evidence: Removal information only - not a dialysis regimen

CHEMET oral succimer for its pediatric lead-poisoning indication; not prophylaxis or treatment of lead encephalopathy.

Renal method: Qualitative renal impairment; monitoring rather than numeric dose bands
Retrieved: 2026-09-10

Read local renal resultOpen original reference

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Product / population check

Confirm the exact formulation before using a renal source

These links compare product identities, not interchangeable doses. A selected summary is not a complete prescribing monograph.

Source-specific review points

Removal of drug is not equivalent to removal of lead chelates

Read the attributed comparison notes and source cards below. No conflict has been silently adjudicated.

Source-quality holds
Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources
Jump to renal guidanceRead 1 difference / caution notesClinician guide

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

drug versus chelate removal

Removal of drug is not equivalent to removal of lead chelates

The selected official and mirror sections distinguish drug dialyzability from chelate removal.

How to use this: Keep toxicology assessment and monitoring attached. Do not derive a dialysis supplement from removal information alone.

GlobalRPh RX List - CHEMETCHEMET - succimer capsules

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Original content / product scopeCHEMET - succimer capsulesGlobalRPh RX List - CHEMET
Choose two source checkboxes below.
Exact product and population matter. This added page contains locally stored, source-specific clinical summaries. Historical handbook information, when present, is identified separately and may conflict with U.S. labeling. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Exact product and population

Product identity selected for the separately displayed source protocols below. Reference: https://globalrph.com/rx-list/chemet-drug/

Exact product and population

CHEMET oral succimer for its pediatric lead-poisoning indication; not prophylaxis or treatment of lead encephalopathy.

RDM58-SCOPE-succimer-chemet · Source section: Selected source product scopeRenal section finder
Separate U.S. product-label layer

FDA / DailyMed dosing and renal information

Official

CHEMET - succimer capsules

Open original reference

Open / share this exact local source

DailyMed / Recordati Rare Diseases Inc. · CHEMET oral succimer for its pediatric lead-poisoning indication; not prophylaxis or treatment of lead encephalopathy.

Renal method: Qualitative renal impairment; no numeric clearance threshold supplied
Source date: 9/2024
Retrieved: 2026-09-10

Monitoring or renal-toxicity guidance. This finding concerns risk or surveillance; it may not establish a dose adjustment.

Dialysis evidence: Removal information only - not a dialysis regimen

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

The full prescribing-information renal subsection (8.5) supports baseline and periodic renal assessment during prolonged therapy, adequate hydration, and closer monitoring with a renal-impairment history. It distinguishes limited evidence of succimer dialyzability from non-dialyzability of lead chelates.

No clearance-band reduction or dialysis supplement is established by this paragraph. CBC/neutrophil and hepatic monitoring remain separate treatment safeguards. Follow the full renal subsection heading rather than relying solely on a highlights cross-reference.

RDM58-official-succimer-chemet-0082c53ab7-C1 · Source locator: Full PI 8.5 (Renal Impairment); sections 2.1 and 5.2-5.3

Source-specific limits

Selected sections only; not a complete prescribing monograph or independent clinician approval.

Exact DailyMed HTML identity and named sections read. Raw SPL XML, original document hash and complete revision history were not obtained. Availability is not established by label retrieval.

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62035612-9505-3a3f-1ac8-e2dbd711d24e
Retrieved
2026-09-10
Exact label title
CHEMET - succimer capsules
DailyMed Set ID
62035612-9505-3a3f-1ac8-e2dbd711d24e
Labeler
Recordati Rare Diseases Inc.
Label revision
9/2024
Renal-function method
Qualitative renal impairment; no numeric clearance threshold supplied
Source date/version
9/2024
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
9353012ea23eec2aaf54f221ec87e8d25e8645160178b2027f13cd2ba96ef577
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - CHEMET

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · CHEMET oral succimer for its pediatric lead-poisoning indication; not prophylaxis or treatment of lead encephalopathy.

Renal method: Qualitative renal impairment; monitoring rather than numeric dose bands
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-10

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Monitoring or renal-toxicity guidance. This finding concerns risk or surveillance; it may not establish a dose adjustment.

Dialysis evidence: Removal information only - not a dialysis regimen

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

Assess renal function before therapy and periodically during prolonged treatment; monitor more frequently with pre-existing impairment and maintain adequate hydration. Limited evidence suggests succimer is dialyzable but its lead chelates are not.

Drug removal alone is not proof of effective lead-chelate clearance. The selected renal subsection supplies monitoring guidance, not a numeric renal reduction or dialysis replacement dose.

RDM58-rxlist-succimer-chemet-045e3242fd-C1 · Source locator: Use in Specific Populations: Renal Impairment

Source-specific limits

Selected sections only; not a complete prescribing monograph or independent clinician approval.

A hosted label mirror is not independent corroboration of its underlying label. Official confirmation remains pending unless a separate official card is shown.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/chemet-drug/
Retrieved
2026-09-10
Renal-function method
Qualitative renal impairment; monitoring rather than numeric dose bands
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only; not original HTML, PDF or SPL bytes.
Local summary SHA-256
8c1e17a4e4e2538f710b7711b6d6b52ed7b2a9b6fc4a6b3fb69e6277dec3ea4f

Provenance and preservation

Additional summaries stored on this page: 1 official-label, 1 RX List, 0 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/rx-list/chemet-drug/
Source retrieval
2026-09-10. This is not the source publication or label revision date.
Original source type
rxlist summary
Local text SHA-256
9dca0f641edb3fa7df4df6d3e760845c9fbabea0b6d2713bb815c3017252c82a
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

This page is an additional exact-product entry, not a recovered GlobalRPh monograph. Its primary scope text and separately attributed clinical summaries are locally included.

Read the full coverage report